Compounds > naltrexone

naltrexone and Liposclerotic Mesenteritis

naltrexone has been researched along with Liposclerotic Mesenteritis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexoff, A; Ehrenpreis, ED; Roginsky, G1

Trials

1 trial(s) available for naltrexone and Liposclerotic Mesenteritis

ArticleYear
Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis.
    Journal of clinical gastroenterology, 2015, Volume: 49, Issue:9

    Topics: Adult; Dose-Response Relationship, Drug; Humans; Naltrexone; Narcotic Antagonists; Panniculitis, Peritoneal; Pilot Projects; Treatment Outcome

2015